Literature DB >> 15906767

Association with selected bacteria does not cause enterocolitis in IL-10 gene-deficient mice despite a systemic immune response.

Beate C Sydora1, Michele M Tavernini, Jason S G Doyle, Richard N Fedorak.   

Abstract

Resident bacteria have been implicated to play a major role in the development of inflammatory bowel disease. While luminally sterile IL-10 gene-deficient mice remain disease-free, their conventionally raised littermates develop enterocolitis associated with increased numbers of luminal and mucosal adherent bacteria. To investigate the role of defined bacteria on the initiation and development of this enterocolitis, we associated luminally sterile IL-10 gene-deficient mice with pure strains of resident bacteria. Axenic, luminally sterile mice were either monoassociated with viridans group Streptococcus or Clostridium sordellii or co-associated with Bacteroides vulgatus and Clostridium sordellii. Seven to 22 weeks later the mice were analyzed for intestinal histologic injury, epithelial permeability, and an inflammatory immune response to bacterial antigens. Despite optimal colonization none of the tested bacteria caused intestinal inflammation, release of inflammatory cytokines from the epithelia, or disruption of the epithelial barrier integrity. However, in the case of association with Bacteroides vulgatus and Clostridium sordellii, a systemic immune response to bacterial-derived antigens was measured, with a magnitude similar to that seen in conventional sick Il-10 gene-deficient mice. This response was not detected in mice associated with viridans group Streptococcus. We conclude that colonization of the intestinal lumen with individual bacterial species may not be sufficient to alter epithelial barrier integrity, increase intestinal cytokine release, or cause intestinal inflammation in susceptible IL-10 gene-deficient mice, despite the ability of these same bacteria to stimulate a systemic response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15906767     DOI: 10.1007/s10620-005-2663-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  The expression and regulation of class II antigens in normal and inflammatory bowel disease peripheral blood monocytes and intestinal epithelium.

Authors:  P Salomon; A Pizzimenti; A Panja; A Reisman; L Mayer
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

Review 2.  The influence of normal microbial flora on the development of chronic mucosal inflammation.

Authors:  R B Sartor
Journal:  Res Immunol       Date:  1997 Oct-Dec

3.  Clustering of increased small intestinal permeability in families with Crohn's disease.

Authors:  M Peeters; B Geypens; D Claus; H Nevens; Y Ghoos; G Verbeke; F Baert; S Vermeire; R Vlietinck; P Rutgeerts
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

4.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

5.  Probiotic bacteria enhance murine and human intestinal epithelial barrier function.

Authors:  K Madsen; A Cornish; P Soper; C McKaigney; H Jijon; C Yachimec; J Doyle; L Jewell; C De Simone
Journal:  Gastroenterology       Date:  2001-09       Impact factor: 22.682

6.  T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans.

Authors:  R Duchmann; E May; M Heike; P Knolle; M Neurath; K H Meyer zum Büschenfelde
Journal:  Gut       Date:  1999-06       Impact factor: 23.059

7.  Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.

Authors:  A Hillary Steinhart; Brian G Feagan; Cindy J Wong; Margaret Vandervoort; Shelley Mikolainis; Kenneth Croitoru; Ernest Seidman; Desmond J Leddin; Alain Bitton; Eric Drouin; Albert Cohen; Gordon R Greenberg
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

8.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

9.  Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats.

Authors:  H C Rath; J S Ikeda; H J Linde; J Schölmerich; K H Wilson; R B Sartor
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

10.  Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Authors:  H C Rath; M Schultz; R Freitag; L A Dieleman; F Li; H J Linde; J Schölmerich; R B Sartor
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

View more
  8 in total

1.  Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis.

Authors:  Takayuki Kajiura; Tomoko Takeda; Shinji Sakata; Mitsuo Sakamoto; Masaki Hashimoto; Hideki Suzuki; Manabu Suzuki; Yoshimi Benno
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

2.  Mechanism of interleukin-1β induced-increase in mouse intestinal permeability in vivo.

Authors:  Rana Al-Sadi; Shuhong Guo; Karol Dokladny; Matthew A Smith; Dongmei Ye; Archana Kaza; D Martin Watterson; Thomas Y Ma
Journal:  J Interferon Cytokine Res       Date:  2012-07-20       Impact factor: 2.607

Review 3.  Bacteria, inflammation, and colon cancer.

Authors:  Liying Yang; Zhiheng Pei
Journal:  World J Gastroenterol       Date:  2006-11-14       Impact factor: 5.742

4.  Naturally occurring glycoalkaloids in potatoes aggravate intestinal inflammation in two mouse models of inflammatory bowel disease.

Authors:  Vadim Iablokov; Beate C Sydora; Rae Foshaug; Jon Meddings; Darcy Driedger; Tom Churchill; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2010-03-03       Impact factor: 3.199

5.  Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

Authors:  James P Moran; Jens Walter; Gerald W Tannock; Susan L Tonkonogy; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2009-07       Impact factor: 5.325

6.  Oral administration of curcumin emulsified in carboxymethyl cellulose has a potent anti-inflammatory effect in the IL-10 gene-deficient mouse model of IBD.

Authors:  Victoria Y L Ung; Rae R Foshaug; Sarah M MacFarlane; Thomas A Churchill; Jason S G Doyle; Beate C Sydora; Richard N Fedorak
Journal:  Dig Dis Sci       Date:  2009-06-10       Impact factor: 3.199

7.  Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota.

Authors:  Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad
Journal:  BMC Gastroenterol       Date:  2010-11-12       Impact factor: 3.067

Review 8.  Infections and autoimmunity: a panorama.

Authors:  V Pordeus; M Szyper-Kravitz; R A Levy; N M Vaz; Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.